Question 1: As the study is jointly funded, what impact does this have on the current cash runway to end FY24?
Question 2: Even with no impact (assuming fully funded or considered), there appears to be sufficient cash for 12 months, which really means there needs to be a a funding update either this or next quarter. Will it be CR or partnership. My bet would be partnership of sorts, fingers crossed it's not from a position of weakness.
- Forums
- ASX - By Stock
- IMM
- Ann: Approval to start Efti & Bavencio trial in urothelial cancer
Ann: Approval to start Efti & Bavencio trial in urothelial cancer, page-2
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
40.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $581.0M |
Open | High | Low | Value | Volume |
40.0¢ | 41.0¢ | 39.5¢ | $736.2K | 1.830M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 269404 | 40.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.5¢ | 136638 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 256446 | 0.400 |
11 | 404151 | 0.395 |
8 | 110880 | 0.390 |
7 | 97979 | 0.385 |
11 | 244956 | 0.380 |
Price($) | Vol. | No. |
---|---|---|
0.405 | 75525 | 15 |
0.410 | 424958 | 19 |
0.415 | 314695 | 14 |
0.420 | 507544 | 11 |
0.425 | 82174 | 5 |
Last trade - 13.51pm 11/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |